Charlotte Guyader

1.1k total citations
16 papers, 846 citations indexed

About

Charlotte Guyader is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Charlotte Guyader has authored 16 papers receiving a total of 846 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 7 papers in Oncology and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Charlotte Guyader's work include Prostate Cancer Treatment and Research (5 papers), DNA Repair Mechanisms (3 papers) and PARP inhibition in cancer therapy (3 papers). Charlotte Guyader is often cited by papers focused on Prostate Cancer Treatment and Research (5 papers), DNA Repair Mechanisms (3 papers) and PARP inhibition in cancer therapy (3 papers). Charlotte Guyader collaborates with scholars based in France, Netherlands and Switzerland. Charlotte Guyader's co-authors include Patricia de Crémoux, Anne Vincent‐Salomon, Franck Assayag, Ludmilla de Plater, Elisabetta Marangoni, Marie‐France Poupon, Nathalie Auger, Olivier Delattre, Gonzague de Pinieux and Sven Rottenberg and has published in prestigious journals such as The EMBO Journal, PLoS ONE and Cancer Research.

In The Last Decade

Charlotte Guyader

15 papers receiving 833 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Charlotte Guyader France 10 443 420 214 115 99 16 846
Juliann Shih United States 8 361 0.8× 396 0.9× 303 1.4× 58 0.5× 118 1.2× 10 930
Victoria da Silva-Diz United States 9 616 1.4× 691 1.6× 345 1.6× 50 0.4× 87 0.9× 16 1.1k
Thomas R. Geiger United States 10 422 1.0× 627 1.5× 245 1.1× 40 0.3× 87 0.9× 14 1.0k
Lucia Borriello United States 16 373 0.8× 474 1.1× 274 1.3× 47 0.4× 83 0.8× 27 984
Nathalie Cahuzac France 10 467 1.1× 604 1.4× 195 0.9× 72 0.6× 45 0.5× 10 954
Yunyuan V. Wang United States 7 592 1.3× 1.3k 3.2× 228 1.1× 92 0.8× 38 0.4× 7 1.5k
Matteo Rossi Italy 14 323 0.7× 687 1.6× 295 1.4× 61 0.5× 33 0.3× 19 972
Cheryl J. Aslakson United States 6 539 1.2× 553 1.3× 220 1.0× 103 0.9× 85 0.9× 8 1.2k
Dorothy Markowitz United States 8 643 1.5× 495 1.2× 251 1.2× 82 0.7× 85 0.9× 9 1.0k
Mahak Singhal Germany 14 321 0.7× 506 1.2× 302 1.4× 41 0.4× 86 0.9× 18 884

Countries citing papers authored by Charlotte Guyader

Since Specialization
Citations

This map shows the geographic impact of Charlotte Guyader's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charlotte Guyader with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charlotte Guyader more than expected).

Fields of papers citing papers by Charlotte Guyader

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Charlotte Guyader. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charlotte Guyader. The network helps show where Charlotte Guyader may publish in the future.

Co-authorship network of co-authors of Charlotte Guyader

This figure shows the co-authorship network connecting the top 25 collaborators of Charlotte Guyader. A scholar is included among the top collaborators of Charlotte Guyader based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Charlotte Guyader. Charlotte Guyader is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Gerhards, Nora M., Vincent A. Blomen, Merve Mutlu, et al.. (2018). Haploid genetic screens identify genetic vulnerabilities to microtubule‐targeting agents. Molecular Oncology. 12(6). 953–971. 10 indexed citations
2.
Blatter, Sohvi, Nadine Stokar‐Regenscheit, Ariena Kersbergen, Charlotte Guyader, & Sven Rottenberg. (2018). Chemotherapy induces an immunosuppressive gene expression signature in residual BRCA1/p53-deficient mouse mammary tumors. 1(1). 6 indexed citations
3.
Pajic, Marina, Sohvi Blatter, Charlotte Guyader, et al.. (2017). Selected Alkylating Agents Can Overcome Drug Tolerance of G0-like Tumor Cells and Eradicate BRCA1-Deficient Mammary Tumors in Mice. Clinical Cancer Research. 23(22). 7020–7033. 20 indexed citations
4.
Planells‐Cases, Rosa, Charlotte Guyader, Nora M. Gerhards, et al.. (2015). Subunit composition of VRAC channels determines substrate specificity and cellular resistance to P t‐based anti‐cancer drugs. The EMBO Journal. 34(24). 2993–3008. 209 indexed citations
5.
Blatter, Sohvi, Charlotte Guyader, Aslι Küçükosmanoğlu, et al.. (2015). Abstract 736: Combining PD1- and CTLA4-inhibiting antibodies with cisplatin or PARP inhibition in an attempt to eradicate BRCA1-deficient mouse mammary tumors. Cancer Research. 75(15_Supplement). 736–736. 1 indexed citations
6.
Jaspers, Janneke E., Wendy Sol, Ariena Kersbergen, et al.. (2014). BRCA2-Deficient Sarcomatoid Mammary Tumors Exhibit Multidrug Resistance. Cancer Research. 75(4). 732–741. 53 indexed citations
7.
Guyader, Charlotte, Jocelyn Céraline, Eléonore Gravier, et al.. (2012). Risk of Hormone Escape in a Human Prostate Cancer Model Depends on Therapy Modalities and Can Be Reduced by Tyrosine Kinase Inhibitors. PLoS ONE. 7(8). e42252–e42252. 15 indexed citations
8.
Reyal, Fabien, Charlotte Guyader, Charles Decraene, et al.. (2012). Molecular profiling of patient-derived breast cancer xenografts. Breast Cancer Research. 14(1). R11–R11. 140 indexed citations
9.
Plater, Ludmilla de, Anthony Laugé, Charlotte Guyader, et al.. (2010). Establishment and characterisation of a new breast cancer xenograft obtained from a woman carrying a germline BRCA2 mutation. British Journal of Cancer. 103(8). 1192–1200. 33 indexed citations
10.
Dahmani, Ahmed, Ludmilla de Plater, Charlotte Guyader, et al.. (2010). A preclinical therapeutic schedule optimizing docetaxel plus estramustine administration in prostate cancer. Anti-Cancer Drugs. 21(10). 927–931. 2 indexed citations
11.
Cottu, P., Franck Assayag, Ludmilla de Plater, et al.. (2010). Abstract S6-7: Establishment and Characterization of Human Luminal Breast Cancer Xenografts. Cancer Research. 70(24_Supplement). S6–7. 1 indexed citations
12.
Legrier, Marie‐Emmanuelle, Charlotte Guyader, Jocelyn Céraline, et al.. (2008). Hormone escape is associated with genomic instability in a human prostate cancer model. International Journal of Cancer. 124(5). 1103–1111. 5 indexed citations
13.
Oudard, Stéphane, Charlotte Guyader, Gonzague de Pinieux, et al.. (2007). Potentiation of antitumour activity of docetaxel by combination with trastuzumab in a human prostate cancer xenograft model and underlying mechanisms. British Journal of Cancer. 96(2). 269–276. 21 indexed citations
14.
Oudard, Stéphane, Eugéniu Banu, Florian Scotté, et al.. (2007). [New targeted therapies in hormone-refractory prostate cancer].. PubMed. 94(7 Suppl). F62–8. 1 indexed citations
15.
Marangoni, Elisabetta, Anne Vincent‐Salomon, Nathalie Auger, et al.. (2007). A New Model of Patient Tumor-Derived Breast Cancer Xenografts for Preclinical Assays. Clinical Cancer Research. 13(13). 3989–3998. 307 indexed citations
16.
Nibart, M., et al.. (1992). DNA probe sexing of young in vitro fertilized bovine embryos. Theriogenology. 37(1). 253–253. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026